BioCentury
ARTICLE | Financial News

Guardant gets pop after IPO; Kodiak prices below range

October 4, 2018 2:06 PM UTC

Liquid biopsy company Guardant Health Inc. (NASDAQ:GH) and ophthalmic company Kodiak Sciences Inc. (NASDAQ:KOD) each priced IPOs late Wednesday. Guardant priced above its proposed range and posted a big gain on Thursday, while Kodiak priced below expectations and traded modestly above its offering price.

Biotechs raised $4.7 billion in NASDAQ listings across the first nine months of 2018. The total exceeds full-year proceeds from NASDAQ listings in 2017, and could surpass the $5.2 billion record in 2015 (see "Paper Chase")...